Projecten per jaar
Persoonlijk profiel
Expertise
I am a PhD student currently employed at the Laboratory for Molecular and Cellular Therapy (LMCT, VUB). I have obtained a Master degree in Biomedical Sciences at the Vrije Universiteit Brussel. My PhD project is a joint project between the LMCT and ICMI research groups in which I will focus on the development of an in vivo nanoCAR-T cell therapy.
Vingerafdruk
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
-
FWOSB101: CARGO: bevorderen van chimere antigen receptor T-celtherapie m.b.v. nanobody bevattende lentivirale vectoren.
1/11/20 → 31/10/24
Project: Fundamenteel
-
IOFPOC42: IOF proof of Concept: Modificatie van T-cellen in situ om de functionaliteit te wijzigen.
Devoogdt, N., Breckpot, K., Meeus, F., De Groof, T. & De Vlaeminck, Y.
1/01/21 → 31/12/22
Project: Toegepast
Onderzoeksoutput
- 20 Citaties
- 2 h-index
- 2 Article
-
Emerging applications of nanobodies in cancer therapy
Awad, R. M., Meeus, F., Ceuppens, H., Ertveldt, T., Hanssens, H., Lecocq, Q., Mateusiak, L., Zeven, K., Valenta, H., De Groof, T. W. M., De Vlaeminck, Y., Krasniqi, A., De Veirman, K., Goyvaerts, C., D'Huyvetter, M., Hernot, S., Devoogdt, N. & Breckpot, K., 2022, In: International review of cell and molecular biology. 369, blz. 143-199 57 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand7 Citaten (Scopus)180 Downloads (Pure) -
The antigen-binding moiety in the driver's seat of CARs
Hanssens, H., Meeus, F., De Veirman, K., Breckpot, K. & Devoogdt, N., jan 2022, In: Medicinal Research Reviews. 42, 1, blz. 306-342 37 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand13 Citaten (Scopus)15 Downloads (Pure)
Activiteiten
-
Development of an in vitro hot tumor model for immunotherapeutic drug screening
Robin Maximilian Awad (Presenter), Fien Meeus (Contributor), Yannick De Vlaeminck (Contributor), Nick Devoogdt (Contributor) & Karine Breckpot (Contributor)
21 sep 2022Activiteit: Talk or presentation at a conference
-
Human relevant models for drug research and development
Fien Meeus (Speaker), Robin Maximilian Awad (Contributor), Nick Devoogdt (Contributor), Sandra Tuyaerts (Contributor), Cleo Goyvaerts (Contributor), Yannick De Vlaeminck (Contributor), Bart Neyns (Contributor) & Karine Breckpot (Contributor)
8 okt 2021Activiteit: Talk or presentation at a workshop/seminar
-
2021-80
Nick Devoogdt (Supervisor), Timo De Groof (Contributor), Fien Meeus (Contributor), Karine Breckpot (Contributor) & Yannick De Vlaeminck (Contributor)
2021 → …Activiteit: Other
Knipsels
-
Betaalbare kankerimmunotherapie
Karine Breckpot, Nick Devoogdt, Yannick De Vlaeminck & Fien Meeus
8/02/22
1 item van Media-aandacht
Pers / media: !!Research
-
VUB-onderzoek naar gedeeltelijk falen immuuntherapie
Karine Breckpot, Fien Meeus & Yannick De Vlaeminck
3/02/22
1 Mediabijdrage
Pers / media: !!Research
-
VUB-onderzoekers en start-up Esobiotec streven naar betaalbare kankerimmunotherapie
Karine Breckpot, Nick Devoogdt, Yannick De Vlaeminck & Fien Meeus
31/01/22
1 Mediabijdrage
Pers / media: !!Research
-
VUB-onderzoekers en start-up Esobiotec willen kankerimmunotherapie betaalbaarder maken
Karine Breckpot, Nick Devoogdt, Fien Meeus & Yannick De Vlaeminck
31/01/22
1 item van Media-aandacht
Pers / media: !!Research
Scriptie
-
Assessment of antigen-binding domain parameters important for adequate CAR-T-cell activation: evaluating different SLAMF7-targeting nanobodies.
Auteur: Meeus, F., Hanssens, H., De Veirman, K. & Devoogdt, N., 19 jun 2020Begeleider: Hanssens, H. (Advisor)
Scriptie/Masterproef: Master's Thesis